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Abstract
Background: In different models of hypoxia, blockade of opioid or N-methyl-D-aspartate (NMDA) receptors shows
cardio- and neuroprotective effects with a consequent increase in animal survival. The aim of the study was to
investigate effects of pre-treatment with Morphine or Ketamine on hemodynamic, acid-base status, early survival,
and biochemical markers of brain damage in a rat model of asphyxial cardiac arrest (ACA).
Methods: Under anaesthesia with Thiopental Sodium 60mg/kg, i.p., Wistar rats (n = 42) were tracheostomized and
catheters were inserted in a femoral vein and artery. After randomization, the rats were pre-treated with: Morphine
5 mg/kg i.v. (n = 14); Ketamine 40 mg/kg i.v. (n = 14); or equal volume of i.v. NaCl 0.9% as a Control (n = 14). ACA
was induced by corking of the tracheal tube for 8 min, and defined as a mean arterial pressure (MAP) < 20 mmHg.
Resuscitation was started at 5 min after cardiac arrest (CA). Invasive MAP was recorded during experiments. Arterial
pH and blood gases were sampled at baseline (BL) and 10 min after CA. At the end of experiments, all surviving
rats were euthanised, brain and blood samples for measurement of Neuron Specific Enolase (NSE), s100 calcium
binding protein B (s100B) and Caspase-3 (CS-3) were retrieved.
Results: At BL no differences between groups were found in hemodynamic or acid-base status. After 3 min of
asphyxia, all animals had cardiac arrest (CA). Return of spontaneous circulation (MAP > 60 mmHg) was achieved in
all animals within 3 min after CA. At the end of the experiment, the Ketamine pre-treated group had increased
survival (13 of 14; 93%) compared to the Control (7 of 14; 50%) and Morphine (10 of 14; 72%) groups (p = 0.035).
Biochemical analysis of plasma concentration of NSE and s100B as well as an analysis of CS-3 levels in the brain
tissue did not reveal any differences between the study groups.
Conclusion: In rats after ACA, pre-treatment with Morphine or Ketamine did not have any significant influence on
hemodynamic and biochemical markers of brain damage. However, significantly better pH level and increased early
survival were found in the Ketamine pre-treated group.
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Background
Almost 35 years ago, Dr. Peter Safar wrote that “cere-
bral recovery from more than 5 min of cardiac arrest is
hampered by complex secondary derangements of
multiple organ systems after reperfusion” [1]. Actually,
these 5 “golden” minutes determine the ability of cere-
bral neurones to regain ordinary function after anoxia.
The ordinary function of cerebral neurones is conduc-
tion of electrical impulses across their length from the
post-synaptic membrane of dendrites to the presynaptic
membrane of an axon. The process is based on ex-
change of Ca2+, Na+ and K+ between the extra- and
intracellular space of cerebral neurones, and therefore a
lot of energy in the form of adenosine triphosphate
(ATP) is needed to remove Ca2+ and Na+ from the
intracellular space of these cells. Cardiac arrest (CA)
initiates a switch to anaerobic metabolism with very
low production of ATP [2] and the increased [2] levels
of lactate and H+. Both acidosis and the lack of ATP
inhibit the ions pumps, which are responsible for hand-
ling excessive intracellular accumulation of Ca2+ and
Na+ [2]. Moreover, preclinical studies demonstrate that
acute hypoxia results in an uncontrolled release of glu-
tamate with consequent stimulation of the N-methyl-
D-aspartate (NMDA) receptors causing an excessive
Ca2+ influx [3–8]. Meanwhile, the ATP reservoir in
neurones can be completely depleted after 5 min of no-
flow state. In case of oxygen supplying restoration, two
molecules of ATP are initially required to split glucose
and restart the cellular respiration. Thus, the presence
or absence of these two molecules of ATP in neurones
actually determines restoring of both oxidative phos-
phorylation and the ordinary function of the neurones.
Finally, prolonged intracellular Ca2+ overload results in
increased mitochondrial permeability causing following
release of cytochrome C from mitochondria, and con-
sequent cleavage and activation of caspase-3 [9, 10].
Caspase-3 is an essential protease, which is involved in
the early stage of apoptosis and it is generally accepted
as a hallmark of irreversible cell death [10]. Recently,
early elevated blood levels of two specific biochemical
markers of neuronal damage, namely neuron-specific
enolase (NSE) and S-100B protein, were also found to
be associated with illness severity on hospital arrival,
and with poor outcome after cardiac arrest [11]. Today,
only therapeutic hypothermia has been shown to have a
beneficial impact on the ion pump dysfunction, and
thereby reduce neurotoxicity [12]. Interestingly, in
hibernators, hypothermia is also believed to protect
against hypoxic brain damage [13]. Meanwhile, if
naloxone, a non-selective opioid receptor antagonist, is
injected during the maintenance phase of hibernation,
arousal is quickly achieved and the protective effects
will vanish [13]. Delta opioid peptides, previously
discovered to induce hibernation, have also been shown
to protect rats from hypoxic brain damage [14]. Based
on the ability of opioids to reduce the level of cyclic ad-
enosine monophosphate (cAMP), and consequently to
block Na+ channels, it would be logic to propose that
opioids might prevent the disturbance of ionic homeo-
stasis during acute hypoxia. Indeed, preclinical studies
demonstrate that pre-treatment with opioids can pre-
serve cellular integrity after acute hypoxia in many or-
gans and tissues including: intestine [15], skeletal
muscle [16], myocardium [17, 18] and brain [19, 20].
Moreover, Morphine has been shown to significantly
increase the early survival of mice and rats after acute
hypoxia condition [21, 22]. Opioid receptor agonists
also have demonstrated to cause increased tissue pres-
ervation and survival time of organs before their use in
transplantation surgery [23]. In addition, high doses of
opioids have been shown to inhibit NMDA receptors
[24]. Other experimental studies have shown that
inhibition of the NMDA receptor by Ketamine may
reduce neuronal apoptosis and attenuate the systemic
inflammatory response to tissue injury [25–27]. More-
over, the sympathomimetic effects of Ketamine might
help to facilitate recovery of systemic blood pressure
during cardiopulmonary resuscitation (CPR) [28]. All
anaesthetics, with their ability to antagonise glutamate-
mediated excitotoxicity and inflammation might be the
logic candidates for neuroprotective treatment during
cardiac arrest. However, the additional ability of most
anaesthetics to produce vasodilatation with a significant
reduction of blood pressure can be the main argument
against the idea to test their effects during CPR in
humans. Theoretically, due to their minimal influences
on hemodynamic status, Ketamine as well as Morphine
might be considered as the safe candidates during neu-
roprotective treatment trials in CPR patients. However,
we were not able to find any preclinical studies explor-
ing the influence of Morphine or Ketamine application
before or during CPR on arterial blood pressure blood gas
tension, and early survival. Thus, the aim of this experimental
study in a rat model of asphyxial cardiac arrest (ACA) was to
investigate the influence of pre-treatment with Morphine or
Ketamine on hemodynamics, acid-base status, brain damage
markers, and early survival as endpoint of the study.
Methods
Ethics
The experimental study was approved by the Animal Care
and Use Committee of the Astana Medical University,
Astana, The Republic of Kazakhstan. The experimental
procedures were performed according to the Guide for
the Care and Use of Laboratory Animals, Eighth Edition,
2011 formulated by National Academy of Sciences, the
United States of America.
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Animal housing
A total of 42 adult male Wistar rats, weighing 350–400 g
were pushed from Astana Laboratory Animal Center,
Astana, the Republic of Kazakhstan. All experiments
were performed in the Experimental Animal Center,
Astana Medical University, Astana, the Republic of
Kazakhstan. The rats were housed in stainless steel cages
(5 rats/cage) at conventional controlled conditions
(temperature 25 ± 2 °C; relative humidity 50 ± 10%; 12 h
light: dark cycle) and had a free access to standard
laboratory food and tap water. The rats acclimated to
the condition for 1 week prior to experiments and fasted
overnight prior to surgery, with free access to water.
Animal instrumentation
Under anaesthesia with Thiopental Sodium (Kiev Med-
peparat, Ukraine) 60 mg/kg, i.p., rats were tracheosto-
mized with a stainless-steel tracheal tube, connected to a
small animal ventilator (TOPO Dual mode ventilator,
Kent Scientific Corp, USA) and mechanically ventilated
with a tidal volume of 8 ml/kg using room air. A 24G
central venous catheter (Arrow) was inserted into the
right femoral vein for drug administration and blood
sampling. A 22G catheter (22G venflon, BD, Sweden)
was inserted into the right femoral artery connected to
pressure transducer for continuous blood pressure mon-
itoring using Dash 5000, GE Healthcare, USA. Average
time for the instrumentation was about 10 min. At the
end of the instrumentation the rats were given vecuro-
nium bromide (Pfizer, USA) 2 mg/kg, i.v.
Animal randomization
After instrumentation and following a 10 min pause, by
means of sealed envelopes the rats were randomly
assigned to 3 groups: 1). Morphine group (n = 14), where
the rats were given i.v. Morphine (Chimfarm Santo,
Kazakhstan), 5 mg/kg, 10 min before inducing asphyxial
cardiac arrest (ACA). 2). Ketamine group, (n = 14),
where the rats were given i.v. Ketamine (Farmac,
Ukraine) 40 mg/kg 10 min before ACA, 3). Control
group (n = 14), where the rats were given an equal quan-
tity of NaCl 0.9% 10min before ACA.
Induction of ACA
ACA was induced by corking of the tracheal tube for 8min
(Fig. 1), and defined as a mean arterial pressure
(MAP) < 20mmHg. Cardio-pulmonary resuscitation (CPR)
was initiated by an i.v. injection of epinephrine (0.02mg/
kg), followed by mechanical ventilation (80 breaths/min)
using room air, and manual thoracic compressions (180
compressions/min). Restoration of spontaneous circulation
(ROSC) was defined as a return of MAP > 60mmHg. Venti-
lation was maintained until spontaneous breathing began.
Core temperature (rectal) was kept between 36.5 °C and
37.5 °C using a heating pad. Arterial blood samples were
taken at baseline, and 10min after start of CPR. MAP was
recorded at baseline, after i.v. injection of the study drugs or
saline, at 1, 2, 3, 4, 5min after induction of ACA and at 1, 5,
10, 15, 20min in the post-resuscitation period. All surviving
rats were euthanized with 180mg/kg i.v. of Thiopental
Sodium (Kiev Medpeparat, Ukraine) at the end of study.
Measurement of biochemical markers
Blood samples were centrifuged, plasma were aliquoted
and snap frozen at − 70C. Right after euthanasia brain
was retrieved and brain tissue samples were snap frozen
at − 70 °C. All samples were stored at -70 °C until ana-
lysis. Levels of neuron specific enolase (NSE), and s100
calcium binding protein B (s100B) were measured in
plasma samples which were collected at baseline and at
10 min in the post-resuscitation period (n = 7). Level of
caspase-3 (CS-3) was measured in brain tissue samples
from the surviving rats at the end of the experimental
protocol, 20 min in the post-resuscitation period (n = 7).
CS-3 level was normalized to the protein concentration
in the brain tissue samples and results presented as a
Fig. 1 Experimental protocol timeline. (BL) - baseline; (Inj) - injection of study drug or saline; (As1, 2, 3, 4, or 5) - asphyxia at 1, 2, 3, 4, or 5 min;
(PR1, 5, 10, 15, or 20) - post-resuscitation at 1, 5, 10, 15, or 20 min; (CPR) - cardiopulmonary resuscitation; (ROSC) - return of spontaneous
circulation; (S1) - blood sampling at BL for blood gases and biochemical markers; (S2) - blood sampling at PR10 for blood gases; (S3) - blood and
tissue sampling at PR20 (endpoint)
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concentration per mg protein. All analysis were per-
formed using Enzyme Linked Immunosorbent Assay
(ELISA) kits provided by MyBioSource Inc. (San Diego,
CA, USA). Protein content in the brain tissue samples
was determined using Quick start Bradford protein assay
from Bio-Rad (Hercules, CA, USA).
Statistical analysis
As we were not able to find any experimental study of
Morphine or Ketamine application for animals with as-
phyxial cardiac arrest, for our study we calculated the
sample size based on data from the research study of
Endoh H, et al. [22]. In the experimental study with rats
exposed to hypoxic gas (5% oxygen, 95% N2) for 70 min,
approximately 90% rats survived in the Morphine (5 mg/
kg) pre-treated group, and 40% survived in the control
group. At 5% of significance level and 80% power, sam-
ple size will be pooled prevalence = 0.4 + 0.9/2 = 0.65.
Sample Size = 2 (1.96 + 0.842)2 × 0.65 (1–0.65)/(− 0.5)2 =
14.26.
based on formula of sample size = 2 (Zα/2 + Zβ)2 × P
(1 − P)/(p1 − p2)2.
where Zα/2 = Z0.05/2 = Z 0.025 = 1.96 (From Z table)
at type 1 error of 5% and.
Zβ = Z0.20 = 0.842 (From Z table) at 80% power.
p1 − p2 = Difference in proportion of events in two
groups P = Pooled prevalence = (prevalence in case group
[p1] + prevalence in the control group [p2])/2.
Data were analyzed and presented using SigmaPlot
statistical software version 13.0 (Systat Software Inc.,
San Jose, CA, USA). Data were tested for normal distri-
bution with Shapiro-Wilks test. Differences in values be-
tween groups were analyzed using one-way ANOVA on
ranks. If significant differences were found, all pairwise
multiple comparison procedures using Dunn’s method
was applied to compare values between groups. Blood
gas data and data of biochemical markers made after 10
min in the post-resuscitation period vs. corresponding
baseline levels within each group were compared using a
paired t-test. Survival was tested using log-rank Kaplan-
Meier test. When significant differences were found, all
pairwise multiple comparison procedures were tested
using Holm-Sidak method to compare differences
between groups. Differences were considered significant
at p < 0.05.
Results
At baseline (BL), no significant differences in MAP, blood
gases, or acid-base status were found between groups
(Figs. 2-3, Table 1). As depicted in Fig. 2, pre-treatment of
rats with Ketamine resulted in a significant reduction in
MAP when compared to rats pre-treated with Morphine or
saline. During the first 3min of asphyxia MAP consistently
decreased in all groups resulting in ACA which eventually
took place in all animals when invasive MAP dropped below
20mmHg and remained around zero following 5min of
asphyxia (Fig. 2). Within 3min, after start of CPR the rats in
all groups had ROSC (no differences between the groups)
with regained an invasive MAP > 100mmHg (Fig. 2). At 15
min in post-resuscitation period rats in the Ketamine group
had MAP at a significantly higher level compared to rats in
the Morphine group, however at the 20min post-
resuscitation no significant difference in MAP between
groups was observed. All groups had significantly increased
plasma lactate level (10.5–13mmol/l) compared to their
baseline levels (1.8–3mmol/l) (Fig. 3:A). No significant
Fig. 2 Mean Arterial Pressure (MAP) recorded at baseline (BL), injection of study drug or saline (Inj), asphyxia at 1, 2, 3, 4 or 5 min (As1, 2, 3, 4 or
5), post resuscitation at 1, 5, 10, 15 or 20min (PR1, 5, 10, 15 or 20). *p < 0.05 vs. control group, §p < 0.05 vs. morphine group. Data presented as
mean ± SD, n = 14
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Fig. 3 Serum lactate level (a) and accumulation of H+ in the blood (b) measured at baseline and at 10 min in post resuscitation period. Data
presented as median 25th and 75th percentiles (vertical boxes with a median line), 10th and 90th percentiles (error bars) and 5th and 95th
percentiles (black dots) where # p < 0.05 vs. baseline levels and * p < 0.05 vs. control group
Table 1 Blood gases (mm Hg) and acid base variables measured at the baseline (BL) and at 10 min after asphyxia in post-
resuscitation period (10 PR), p between the groups. Data presented as mean ± SD
morphine ketamine control p
BL 10 PR BL 10 PR BL 10 PR
SaO2 94.1 ± 5.2 66.7 ± 27.3 93.7 ± 7.4 74.1 ± 21.1 93.4 ± 4.3 68.3 ± 23.5 ns
PaO2 90.8 ± 16.5 63 ± 21.7 105 ± 18.9 70.8 ± 33.8 88.7 ± 18.5 64.9 ± 25.8 ns
PaCO2 30.4 ± 12.3 39.1 ± 26.9 28.3 ± 13.6 22.6 ± 12.3 34.3 ± 12.7 36.2 ± 22.6 ns
HCO3 24.4 ± 4.6 10 ± 3.1 24.3 ± 5.1 10.4 ± 3.4 24.4 ± 4.2 10.3 ± 3.7 ns
BE 6 ± 1.7 −19.8 ± 2.3 6.8 ± 2.2 −18.6 ± 4.5 5.2 ± 2.8 −19.9 ± 4.4 ns
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difference in plasma lactate level between groups was ob-
served. All groups had significantly lower pH value 10min
post-resuscitation (7.0–7.2) compared to intragroup baseline
(7.4–7.5) (Fig. 3:B). In addition, rats in the Ketamine group
had significantly lower accumulation of hydrogen ions in
blood as compared to rats in the Control group (Fig. 3:B).
All rats in the study were ventilated with room air only dur-
ing the whole experiment. Only one rat in the Ketamine
treated group died during the post-resuscitation period
(death occurred between 10 and 20min after ROSC). In
contrast to the Ketamine group, significantly higher mortal-
ity (p= 0.035) was observed in the Control group (Fig. 4),
where 7 of 14 rats had not survived 20min after ROSC, 3 of
them had died during the first 10min of the post-
resuscitation period. In the Morphine treated group, totally
4 of 14 rats died within 20min of the post-resuscitation
period, 2 of them had died during the first 10min after
ROSC. No differences in blood gases variables (such as
SaO2, PaO2, PaCO2) and acid-base status variables (HCO3
and BE) were observed between groups. All above
mentioned variables except for PaCO2 were significantly de-
creased compared to intragroup baseline (Table 1). Bio-
chemical analysis of plasma concentration of NSE (Table 2)
and s100 calcium binding protein B (data not shown) as well
as an analysis of caspase-3 levels in the brain tissue (Table 2)
did not reveal any differences between the study groups.
NSE level was significantly increased after 20min of post-
resuscitation period compared to baseline in all three groups
(Table 2).
Discussion
The main finding of the present study was that pre-
treatment of rats with Ketamine significantly
increased early survival after 8 min of asphyxia and
followed by 5 min cardiac arrest. Pre-treatment of rats
with Morphine or Ketamine did not result in any
significant changes of hemodynamic and biochemical
markers of brain damage. However, in the Ketamine
pre-treated group rats had significantly better pH
levels as compared to the Control group.
The rat model of ACA used in our study was devel-
oped by Katz L and co-authors in 1995 [29]. In their
study, the authors presented the reproducible and well-
documented outcome model of asphyxial cardiac arrest
in rats [29]. In this model, rats were anaesthetized with
3% Halothane and 60:40% Nitrous Oxide (N2O):oxygen
(02) and paralyzed with Vecuronium 2mg/kg i. v.
Followed apneic asphyxia for 8 min led to the well re-
producible cessation of blood circulation at 3–4 min of
apnea and cardiac arrest for 4–5 min. Survival to 72 h
after ACA was achieved in 9 of 10 rats (90%) in the
study. All survived rats had mild neurologic deficit
scores that primarily were due to hind-leg spastic pa-
ralysis. However, the paralysis was due to insertion of
arterial and venous catheter in the femoral vessels with
following ligation and cessation of blood circulation in
the leg [29]. In contrast to the «classical» model, in our
study the rats were anesthetized with Thiopental. Re-
cently it was demonstrated that Thiopental significantly
depresses both cardiac and respiratory function, making
cardiac pulmonary resuscitation in rats more difficult
[28]. Definitely, application of Thiopental anaesthesia
and absence of pre- and post-100% oxygenation in our
study resulted in 50% mortality in the Control group
(Fig. 4). The high mortality in our study makes our ex-
perimental model more relevant to clinical situations
Fig. 4 Cumulative survival of the rats at 20 min after CPR, p = 0.035 in ketamine vs. control group, n = 14
Kuklin et al. BMC Anesthesiology          (2019) 19:214 Page 6 of 9
where early survival after in-hospital cardiac arrest
recently was demonstrated approximately to be 50% for
all patients with well-documented cardiac rhythms [30].
Despite on basic anaesthesia with Thiopental, pre-
treatment with Ketamine dramatically increased early
survival (93%) in the rats (Fig. 5). The results are sup-
ported by an earlier finding of Reid KH et al. [28], who
demonstrated a successful restoration of cardiac func-
tion after CA in 81% of rats anesthetized with Ketamine
versus ROSC in 39% rats under Thiopental anaesthesia.
In our opinion, high early survival (90%) in the
«classical» model of Katz L and co-authors [29] might
also be related to NMDA blockade by N2O. Meanwhile,
two experimental studies testing effects of two NMDA
antagonist, MK-801 and GPI-3000 demonstrated no
improvement of survival rate and brain outcome after
CA in a dog model [31, 32]. These studies did not sug-
gest any mechanisms for the negative results, but they
apparently have contributed to a lack of interest for
testing NMDA blockade in CA for years. However, new
published experimental data demonstrates that pre-
treatment of zebrafish with Ketamine protects against
cardiac arrest-induced brain injury by inhibiting Ca2+
wave propagation, which consequently improves sur-
vival rate [33]. More recently, a study of the effects of
using the noncompetitive NMDA antagonist Ifenprodil
demonstrated a significant reduction of brain edema
following CA in rats [34]. In this study, i.v. injection of
Ifenprodil caused a significant reduction of MAP before
CA and much more stable hemodynamic after CA as
compared with saline treated animals [34]. Consistent
with these findings [34], in our study the rats pre-
treated with Ketamine demonstrated a significant re-
duction of MAP right after i.v. injection, but showed a
relatively stable hemodynamic after CA. Summarising
the above, most likely that the sympathomimetic effects
of Ketamine together with subsequent improvement in
pH levels of rats are the main cause for the significant
increment of early survival in our study. As it is not
possible to apply cardiac arrest to animal without any
anaesthesia (main limitation of all experimental models
of cardiac arrest), the sympathomimetic effects and
possible neuroprotective features of Ketamine [35]
should be tested in patients with cardiac arrest.
Additional topic for possible clinical research of
Ketamine as well as Morphine could be their analgesic
effects as vigorous thoracic compression with possible
trauma of the ribs may lead to severe pain and stress
reactions in patients surviving CPR.
In an experimental model with rats exposed to hypoxic
gas (5% 02, 95% N2) for 70min, all seven rats in the Nalox-
one pre-treated group died at the end of the experiments
while only one out of seven rats died in the Morphine (5
mg/kg) pre-treated group, and five of seven rats died in
the control group [22]. The results were very similar to
previously published finding obtained from mice in the
same model [21]. Interestingly, pre-treatment with Mor-
phine in these studies significantly attenuated MAP and
enhanced hypoxic ventilatory depression but, nevertheless,
improved hypoxic survival [21, 22]. In our experiments
where the rats were exposed to 8min anoxia, pre-
treatment with Morphine resulted in non-significant
attenuation of MAP (Fig. 2) and non-significant positive
trend in survival (Fig. 4). We were not able to find any
publications looking at pre-treatment with Morphine and
survival rate in animals after cardiac arrest. However, two
recent retrospective studies demonstrated that patients
who were treated with opioids before or during CA had a
statistically significantly higher survival rate [36] and
much better neurological outcome [37] compared to
untreated patients.
The rationale for analyzing plasma levels of S-100B
protein and NSE in this study was their different distri-
bution within the white (S100B protein) and grey (NSE)
matter of the brain, and the fact that both of them are
extensively involved in the pathogenesis of anoxial brain
damage [38]. S100 B protein is an intracellular calcium-
binding dimer that has a molecular weight of 21 kDa
and a half-life of two hours. Thanks to the low molecu-
lar weight, S100 B easily crosses the blood-brain barrier
and ends up rapidly in the systemic circulation. In this
study, we did not find any changes in the plasma level of
S100 B, and therefore data is not presented. NSE is a
neuronal isoform of the glycolytic enzyme enolase that
has a molecular weight of 78 kDa and a twenty-four
hours half-life. Further, NSE is extensively involved in
glucose metabolism in the neurons and can be detected
only in neuronal and neuroendocrine tissues. Due to this
organ specificity, concentration of NSE in blood is often
elevated because of relative rapid and massive neuronal
Table 2 Biochemical analysis of neuron specific enolase (NSE) plasma concentration in ng/ml and caspase-3 (CS-3) levels in the
brain tissue of the rats in ng/ml/mg protein, measured at the baseline (BL) and at 20 min after asphyxia in post-resuscitation period
(20 PR), p between the groups. Data presented as mean ± SD
morphine ketamine control p
BL 20 PR BL 20 PR BL 20 PR
NSE 1.2 ± 0.1 1.8 ± 0.5 0.9 ± 0.1 3.5 ± 2.2 1.1 ± 0.2 2.4 ± 0.5 ns
CS-3 – 0.14 ± 0.02 – 0.16 ± 0.06 – 0.17 ± 0.05 ns
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destruction. In the present study, plasma levels of NSE
were found to be slightly increased at 20 min after car-
diac arrest in all groups compared to the baseline meas-
urement (Table 2), but the levels did not exceed the
normal range of NSE in blood, considered to be ≤15 ng/
ml. Caspase-3 is involved in the early stage of apoptosis
and is currently considered to be the hallmark of irre-
versible cell death [10]. As depicted in Table 2, tissue
levels of caspase-3 remained low in all study groups and
no significant differences between groups were found.
When summarising all the biochemical findings in the
study, we can conclude that independent of pre-
treatment, there was an absence of biochemical signs of
apoptosis in the rats at 20 min after ACA. Our results
find support in a previous study [39] of post-mortem
adult rat brains, which demonstrated absence of auto-
lytic damages in the ultrastructure of cerebral neurons
during the first 6 h after warm asphyxial cardiac arrest.
Interestingly, in the referred study, the activation of
caspase-3 was observed in a significant number of
neurons of the cerebellum and neocortex only after 9 h
following asphyxial cardiac arrest [39].
Our study has certain limitations. We did not perform
any monitoring of cardiac output in the rats and there-
fore no cardio depressive effect of Morphine or Keta-
mine after ACA was elucidated. However, as arterial
blood pressure and accumulation of lactate were not sig-
nificantly different between the groups we may speculate
whether the negative influence of Morphine or Ketamine
on heart function were clinically irrelevant. We did not
measure brain oxygen demand in our rats, and therefore
the influence of Morphine or Ketamine on oxygen con-
sumption remains unsettled. Finally, rapid intracellular
accumulation of both Na+ and Ca2+ during anoxia might
have contributed to development of brain edema, thus
further research is warranted to elucidate the influence
of Morphine or Ketamine on the development of
cerebral edema after CA.
Conclusions
Pre-treatment with Ketamine before ACA significantly
improved early survival and attenuated alterations in pH
after ROSC when compared to placebo control rats.
Additionally, a positive trend for increased survival was
also observed in the rats pre-treated with Morphine.
Further experimental studies are needed to elucidate
effects of Ketamine and/or Morphine on long-term
survival and neurological outcome after ACA.
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